![]() |
|
|
Vol. 304, Issue 1, 453-463, January 2003
Department of Pharmacobiology, Unit of Pharmacology, University of
Bari, Bari, Italy (A.D.L., S.P., A.L., M.C., C.C., B.F., D.C.C.);
Institute of Neurology, Faculty of Medicine, A. Gemelli Catholic
University, Rome, Italy (M.M., S.S.); and Institute of Pharmacology,
School of Pharmacy, University of Lausanne, Lausanne, Switzerland
(U.T.R.)
A preclinical screening for prompt-to-use drugs that are safer than
steroids and beneficial in Duchenne muscular dystrophy was performed.
Compounds able to reduce calcium-induced degeneration (taurine or
creatine 10% in chow) or to stimulate regeneration [insulin-like
growth factor-1 (IGF-1); 50 or 500 µg/kg s.c.] were administered for
4 to 8 weeks to mdx mice undergoing chronic exercise on a treadmill, a
protocol to worsen dystrophy progression.
-Methyl-prednisolone (PDN;
1 mg/kg) was used as positive control. The effects were evaluated in
vivo on forelimb strength and in vitro electrophysiologically on the
macroscopic chloride conductance (gCl), an index of
degeneration-regeneration events in mdx muscles, and on the mechanical
threshold, a calcium-sensitive index of excitation-contraction
coupling. The exercise produced a significant weakness and an
impairment of gCl, by further decreasing the already low value of
degenerating diaphragm (DIA) and fully hampering the increase of gCl
typical of regenerating extensor digitorum longus (EDL) mdx muscle. The
already negative voltage threshold for contraction of mdx EDL was also
slightly worsened. Taurine > creatine > IGF-1 counteracted
the exercise-induced weakness. The amelioration of gCl was drug- and
muscle-specific: taurine was effective in EDL, but not in DIA muscle;
IGF-1 and PDN were fully restorative in both muscles, whereas creatine
was ineffective. An acute effect of IGF-1 on gCl was observed in vitro
in untreated, but not in IGF-1-treated exercised mdx muscles.
Taurine > PDN > IGF-1, but not creatine, significantly
ameliorated the negative threshold voltage values of the EDL fibers.
The results predict a potential benefit of taurine and IGF-1 for
treating human dystrophy.
This article has been cited by other articles:
![]() |
R. Burdi, J.-F. Rolland, B. Fraysse, K. Litvinova, A. Cozzoli, V. Giannuzzi, A. Liantonio, G. M. Camerino, V. Sblendorio, R. F. Capogrosso, et al. Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests J Appl Physiol, April 1, 2009; 106(4): 1311 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. McLoon Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1505 - H1507. [Full Text] [PDF] |
||||
![]() |
A. Liantonio, V. Giannuzzi, V. Cippone, G. M. Camerino, S. Pierno, and D. C. Camerino Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic Reticulum/Mitochondria Ca2+-Release System J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 626 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Timmons, O. Larsson, E. Jansson, H. Fischer, T. Gustafsson, P. L. Greenhaff, J. Ridden, J. Rachman, M. Peyrard-Janvid, C. Wahlestedt, et al. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy FASEB J, May 1, 2005; 19(7): 750 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Luca, B. Nico, A. Liantonio, M. P. Didonna, B. Fraysse, S. Pierno, R. Burdi, D. Mangieri, J.-F. Rolland, C. Camerino, et al. A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice Am. J. Pathol., February 1, 2005; 166(2): 477 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Basset, F.-X. Boittin, O. M. Dorchies, J.-Y. Chatton, C. van Breemen, and U. T. Ruegg Involvement of Inositol 1,4,5-Trisphosphate in Nicotinic Calcium Responses in Dystrophic Myotubes Assessed by Near-plasma Membrane Calcium Measurement J. Biol. Chem., November 5, 2004; 279(45): 47092 - 47100. [Abstract] [Full Text] [PDF] |
||||